American College of Cardiology 2023

March 4-6, 2023 | New Orleans, LA, USA

The material below is to support scientific exchange. Any content about investigational therapeutics or investigational uses of FDA-approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of FDA approval. 

Alnylam does not recommend or suggest use of its products in any manner inconsistent with the approved Prescribing Information.

Effect of RNAi On Cardiomyopathy and Polyneuropathy Outcomes in Patients with V122I Variant Hereditary Transthyretin-Mediated (hATTR or ATTRv) Amyloidosis

Poster